Turgay Kahraman1, Rahmi Cubuk2, Orhun Sinanoglu3, Nuri Tasalı1, Mumtaz Ozarar1, Bulent Saydam1. 1. Fatih Sultan Mehmet Teaching Hospital, Department of Radiology, Istanbul, Turkey. 2. Maltepe University Faculty of Medicine, Department of Radiology, Istanbul, Turkey. 3. Maltepe University Faculty of Medicine, Department of Urology, Istanbul, Turkey.
Abstract
OBJECTIVE: The aim of this study is to compare the effect of transrectal power Doppler ultrasound (PDUS) and gray scale transrectal ultrasound (TRUS) for the diagnosis of prostate cancer. MATERIALS AND METHODS: Seventy-six patients evaluated with transrectal PDUS and TRUS underwent eight systematic TRUS guided core-needle biopsies, with additional cores from abnormal areas. Histologic diagnoses were classified as benign prostatic hyperplasia, chronic prostatitis, intraepithelial neoplasia and adenocarcinoma. TRUS and PDUS findings of the cases were recorded. RESULTS: PDUS sensitivity, specificity, positive predictive value (PPV) and negative predictive values were 81%, 81%, 54% and 94%, respectively. PDUS had a greater sensitivity and specificity than TRUS (43% and 60%, respectively) and identified cancer cases more accurately (Table 2). CONCLUSION: Hypervascular foci in PDUS signify suitable zones for biopsy. When combined with systematic TRUS guided biopsy, PDUS increases the cancer detection rate with additional biopsies from suspicious hypervascular foci. Transrectal PDUS guided biopsy should be combined with gray scale TRUS guided biopsy to increase accuracy in the diagnosis of prostate cancer.
OBJECTIVE: The aim of this study is to compare the effect of transrectal power Doppler ultrasound (PDUS) and gray scale transrectal ultrasound (TRUS) for the diagnosis of prostate cancer. MATERIALS AND METHODS: Seventy-six patients evaluated with transrectal PDUS and TRUS underwent eight systematic TRUS guided core-needle biopsies, with additional cores from abnormal areas. Histologic diagnoses were classified as benign prostatic hyperplasia, chronic prostatitis, intraepithelial neoplasia and adenocarcinoma. TRUS and PDUS findings of the cases were recorded. RESULTS: PDUS sensitivity, specificity, positive predictive value (PPV) and negative predictive values were 81%, 81%, 54% and 94%, respectively. PDUS had a greater sensitivity and specificity than TRUS (43% and 60%, respectively) and identified cancer cases more accurately (Table 2). CONCLUSION:Hypervascular foci in PDUS signify suitable zones for biopsy. When combined with systematic TRUS guided biopsy, PDUS increases the cancer detection rate with additional biopsies from suspicious hypervascular foci. Transrectal PDUS guided biopsy should be combined with gray scale TRUS guided biopsy to increase accuracy in the diagnosis of prostate cancer.
Authors: F Lee; S Torp-Pedersen; P J Littrup; R D McLeary; T A McHugh; A P Smid; P J Stella; G S Borlaza Journal: Radiology Date: 1989-01 Impact factor: 11.105
Authors: Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun Journal: CA Cancer J Clin Date: 2005 Jan-Feb Impact factor: 508.702
Authors: D Unal; J P Sedelaar; R G Aarnink; G J van Leenders; H Wijkstra; F M Debruyne; J J de la Rosette Journal: BJU Int Date: 2000-07 Impact factor: 5.588
Authors: Ethan J Halpern; Ferdinand Frauscher; Stephen E Strup; Levon N Nazarian; Patrick O'Kane; Leonard G Gomella Journal: Radiology Date: 2002-10 Impact factor: 11.105
Authors: Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman Journal: N Engl J Med Date: 2004-05-27 Impact factor: 91.245